ENG/中
老虎证券
行情
交易
收费
下载
优惠与活动
帮助
TigerAI
机构
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
股权激励
关于
登录
立即注册
Toggle
美股
详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务
美国抗疫概念
1,724.47
-30.1818
-1.72%
涨家数：
- -
跌家数：
19
平家数：
- -
市盈率：
- -
高：
1,756.44
开：
1,754.52
低：
1,720.39
收：
1,754.66
成交量：
3.00亿
成交额：
183.67亿
市值：
1.41万亿
流通市值：
1.39万亿
数据加载中...
总览
新闻资讯
阿斯利康苏博科：中国在技术发展领域处于领先地位
睿见Economy
·
5小时前
雅培公司董事长罗赋德：建议为创新产品提供3-5年的定价弹性期
睿见Economy
·
6小时前
清华大学与阿斯利康签署校级科研合作协议，加速新药研发进程
新京报
·
03/21
肯特郡脑膜炎爆发引发英国疫苗需求激增和政策辩论
路透中文
·
03/21
肯特郡脑膜炎爆发引发英国疫苗需求激增和政策辩论
路透中文
·
03/20
Co-Diagnostics签署协议，大幅扩张南亚地区商业与分销版图
美股速递
·
03/20
背景资料-过去几十年的大宗消费交易
路透中文
·
03/20
外资再加码！医药巨头阿斯利康核药生产供应基地落子黄埔
21世纪经济报道
·
03/19
吉利德科学(GILD.US)CD19/CD20 CAR-T细胞疗法启动III期临床
智通财经
·
03/19
阿斯利康将于广州建设放射性偶联药物生产供应基地
格隆汇
·
03/19
辉瑞：Talzenna联合Xtandi安全性符合各自已知安全特征，未发现新安全信号
美股速递
·
03/19
Talzenna联合Xtandi显著改善转移性前列腺癌患者的影像学无进展生存期
美股速递
·
03/19
落子上海细胞治疗全链条，阿斯利康“深耕中国”迈入新阶段
21世纪经济报道
·
03/19
阿斯利康宣布在上海建立细胞疗法商业化生产供应基地与创新中心
南方财经网
·
03/19
阿斯利康中国区副总裁黄彬突然离职
消费日报财经
·
03/19
再迎阿斯利康重磅布局！浦东生物医药产业究竟有啥“磁场效应”？
上观新闻
·
03/19
分析-TrumpRx 列出的许多药品价格高于在英国支付的价格
路透中文
·
03/19
BUZZ-艾伯维下跌，因强生银屑病药物增加竞争风险
路透中文
·
03/18
强生治疗银屑病的口服药物获美国FDA批准
格隆汇
·
03/18
辉瑞(PFE.US)潜在“first-in-class”小分子组合疗法达主要终点
智通财经
·
03/18
更多
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券 | 轻松买卖美股港股A股/美债/ETF/Crypto/期权期货","description":"老虎证券提供多项优惠：港股&Crypto 0佣、A股通一年免佣、美股期权0佣、IPO打新0融资利息0手续费。 美股1美元起投，免费实时行情与多种工具，立即开户享更多优惠！","keywords":"老虎证券,老虎证券开户,老虎证券香港,老虎证券登录,老虎证券官网,香港证券开户,证券公司开户,股票开户,香港证券公司,香港证券,证券公司,股票投资,投资app,投资平台,股票买卖,股票交易平台,股票app,证券app,新手投资","social":{"ogDescription":"老虎证券提供多项优惠：港股&Crypto 0佣、A股通一年免佣、美股期权0佣、IPO打新0融资利息0手续费。 美股1美元起投，免费实时行情与多种工具，立即开户享更多优惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/BK4568/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK4568","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","market":"US","secType":"PLATE","nameCN":"美国抗疫概念","latestPrice":1724.4738,"timestamp":1774036799999,"preClose":1754.6555,"halted":0,"volume":300102900,"delay":0,"changeRate":-0.017201,"floatShares":0,"shares":0,"eps":0,"marketStatus":"未开盘","change":-30.181763,"latestTime":"03-20 16:00:00 EDT","open":1754.5234,"high":1756.4438,"low":1720.3867,"amount":18367104552.24066,"amplitude":0.020549,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1774272600000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":4.409314,"peRate":25.738578,"turnoverRate":0.02166,"increases":0,"decrements":19,"flats":0,"marketCap":1406737421047.75,"floatMarketCap":1387116339250},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","high":1756.4438,"amplitude":0.020549,"preClose":1754.6555,"low":1720.3867,"pbRate":"4.409314","latestPrice":1724.4738,"volume":300102900,"delay":0,"open":1754.5234,"prevYearClose":1637.1339,"prevWeekClose":1724.4738,"prevMonthClose":1860.0614,"prevQuarterClose":1637.1339,"fiveDayClose":1770.3531,"twentyDayClose":1820.3057,"sixtyDayClose":1643.4171,"secType":"PLATE","market":"US","turnoverRate":0.02166,"peRate":25.738578,"marketCap":1406737421047.75,"floatMarketCap":1387116339250,"timestamp":1774036799999,"nameCN":"美国抗疫概念"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4568\",,,,undefined,":{"bkCode":"BK4568","up":0,"down":19,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4568\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2621726134","title":"阿斯利康苏博科：中国在技术发展领域处于领先地位","url":"https://stock-news.laohu8.com/highlight/detail?id=2621726134","media":"睿见Economy","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621726134?lang=zh_cn&edition=fundamental","pubTime":"2026-03-23 11:18","pubTimestamp":1774235880,"startTime":"0","endTime":"0","summary":" 中国发展高层论坛2026年年会于3月22日至23日在北京举行。在“健康中国2030”与大健康产业发展专题研讨会上，阿斯利康全球首席执行官苏博科强调，中国在技术发展领域处于领先地位，未来几年将在全球医疗健康行业发挥更重要作用：目前全球25%的临床试验在中国开展，30%的全球行业价值流向中国，而10年前这一比例仅为1%，充分彰显了中国在全球医疗领域的重要影响力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/meeting/2026-03-23/doc-inhrxvtx8052868.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU0109394709.USD","LU2417539215.USD","LU0889565916.HKD","BK4588","BK4007","LU0289739699.SGD","LU2456880835.USD","BK4585","BK4568","LU2462157665.USD","BRCD","LU0058720904.USD","LU0320765992.SGD","LU2236285917.USD","IE00B3T34201.USD","AZN","LU1829250122.USD"],"gpt_icon":0},{"id":"2621259857","title":"雅培公司董事长罗赋德：建议为创新产品提供3-5年的定价弹性期","url":"https://stock-news.laohu8.com/highlight/detail?id=2621259857","media":"睿见Economy","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621259857?lang=zh_cn&edition=fundamental","pubTime":"2026-03-23 10:41","pubTimestamp":1774233660,"startTime":"0","endTime":"0","summary":" 中国发展高层论坛2026年年会于3月22日至23日在北京举行。在“健康中国2030”与大健康产业发展专题研讨会上，雅培公司董事长、首席执行官罗赋德表示，进入中国38年来，雅培始终坚守“立足中国、服务中国、服务世界”的长期承诺，并持续深化这一理念。雅培设定的目标是到2030年每年助力改善30亿人的生活，相当于全球每3个人中就有1人受益，而中国是实现这一愿景的关键部分。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/meeting/2026-03-23/doc-inhrxvtw1243540.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU2089984988.USD","LU0114720955.EUR","LU1989763427.SGD","LU1691799644.USD","BK4592","LU2211815571.USD","LU0868494617.USD","ABT","BK4504","BK4588","BK4082","LU2237957811.SGD","BK4581","LU0170899867.USD","LU2468319806.SGD","IE0002141913.USD","SG9999002232.USD","LU2133065610.SGD","IE00B2B36J28.USD","LU1061106388.HKD","LU1057294990.SGD","LU0122379950.USD","LU1721429402.USD","IE00BJT1NW94.SGD","LU2112291526.USD","IE00B4R5TH58.HKD","IE0009355771.USD","LU2324357040.USD","IE00BJJMRZ35.SGD","SGXZ41872573.SGD","LU0882574055.USD","LU1023059063.AUD","SG9999004303.SGD","BK4566","LU0289739699.SGD","LU1989763690.USD","LU0234572021.USD","BK4533","SGXZ23171101.USD","LU1721429741.USD","BK4568","LU2237957902.USD","LU1914381329.SGD","LU0058720904.USD","BK4585","IE00BFTCPJ56.SGD","LU0266013472.USD","SG9999002224.SGD"],"gpt_icon":0},{"id":"2621762898","title":"清华大学与阿斯利康签署校级科研合作协议，加速新药研发进程","url":"https://stock-news.laohu8.com/highlight/detail?id=2621762898","media":"新京报","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621762898?lang=zh_cn&edition=fundamental","pubTime":"2026-03-21 16:48","pubTimestamp":1774082880,"startTime":"0","endTime":"0","summary":"新京报讯（记者王卡拉）3月20日，阿斯利康与清华大学正式签署校级科研合作协议，并宣布成立“清华大学（智能产业研究院）——阿斯利康人工智能药物研发联合研究中心”。该协议旨在建立阿斯利康与清华大学的长期战略合作关系，双方将重点围绕疾病机制研究、多组学分析与数据科学、生物标志物发现、转化医学、临床开发策略、人工智能应用等领域开展合作。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202603213679602747.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603213679602747.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU2236285917.USD","BK4588","LU0058720904.USD","LU0320765992.SGD","LU1829250122.USD","IE00B3T34201.USD","BK4007","BK4568","AZN","LU0889565916.HKD","LU0289739699.SGD","LU2456880835.USD","LU2417539215.USD","BK4585","LU0109394709.USD","LU2462157665.USD"],"gpt_icon":0},{"id":"2621755933","title":"肯特郡脑膜炎爆发引发英国疫苗需求激增和政策辩论","url":"https://stock-news.laohu8.com/highlight/detail?id=2621755933","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621755933?lang=zh_cn&edition=fundamental","pubTime":"2026-03-21 01:59","pubTimestamp":1774029564,"startTime":"0","endTime":"0","summary":"更新版 1-肯特郡脑膜炎爆发引发英国疫苗需求激增和政策辩论肯特郡疫情爆发后乙型脑膜炎疫苗需求激增药房报告疫苗短缺，政府向私人市场发放 20,000 剂 NHS 疫苗在公共卫生辩论中呼吁扩大青少年疫苗接种范围学生报告称等待接种疫苗的时间长达 8 小时第 5-6 段增加了接种疫苗的学生的评论Muvija M/Jennifer Rigby. 担心与肯特郡疫情中的患者有过接触的人可以通过大学校舍、诊所和家庭医生从英国卫生安全局获得疫苗和预防性抗生素。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"37684715aaf54a73b9fe52ee56a263cc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260320:nL4T4081MK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1894683348.USD","BK4592","IE00BBT3K403.USD","IE00B19Z3581.USD","BK5011","LU1400636491.USD","LU1481600234.SGD","LU0203345920.USD","IE0034235071.USD","LU1894683264.USD","LU0109981661.USD","LU1057294990.SGD","LU1228905037.USD","LU1400636657.SGD","LU1098665638.USD","SG9999001176.USD","LU1481599808.USD","SG9999001176.SGD","LU0971552830.HKD","LU1302929846.USD","BK4533","BK4588","LU0306806265.USD","LU1983299246.USD","LU1015430645.USD","BK4550","LU1064927863.SGD","BK4599","LU1046248800.SGD","SG9999011175.SGD","LU0170899867.USD","LU0306807586.USD","GSK.UK","LU0289739699.SGD","LU0985481810.HKD","IE00B19Z3B42.SGD","BK4568","IE00BWDBJ516.SGD","LU1066053197.SGD","IE00B3T34201.USD","LU0122379950.USD","LU0545562505.USD","LU0971552673.USD","LU1670756490.USD","LU0211331839.USD","SG9999013999.USD","LU0321505868.SGD","BK4581","LU1400636574.HKD","LU0161305163.EUR","LU1035777561.USD","LU1202635105.USD","LU0456855351.SGD","BK4534","LU0234572021.USD","SGXZ57979304.SGD","SG9999002224.SGD","LU0868494617.USD","LU1066051498.USD","IE0002270589.USD","SG9999003800.SGD","LU1309081286.SGD","LU1487256676.USD","LU1228905540.USD","IE00BLSP4239.USD","IE00BLSP4452.SGD","LU1023059063.AUD","BK4007","BK4585","LU0058720904.USD","LU0225771236.USD","LU0203347892.USD","IE000M9KFDE8.USD","LU0321505439.SGD","IE00BQJZX424.USD","LU0575583348.USD","LU1645745479.HKD","LU1883839398.USD","LU0225284248.USD","SG9999002232.USD"],"gpt_icon":0},{"id":"2620734824","title":"肯特郡脑膜炎爆发引发英国疫苗需求激增和政策辩论","url":"https://stock-news.laohu8.com/highlight/detail?id=2620734824","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620734824?lang=zh_cn&edition=fundamental","pubTime":"2026-03-20 21:58","pubTimestamp":1774015082,"startTime":"0","endTime":"0","summary":"肯特郡脑膜炎爆发引发英国疫苗需求激增和政策辩论肯特郡疫情爆发后乙型脑膜炎疫苗需求激增药房报告疫苗短缺，政府向私人市场发放 20,000 剂 NHS 疫苗在公共卫生辩论中呼吁扩大青少年疫苗接种范围Muvija M/Jennifer Rigby. 担心与肯特郡疫情中的患者有过接触的人可以通过大学校舍、诊所和全科医生从英国卫生安全局获得疫苗和预防性抗生素。自 2015 年以来，乙型脑膜炎疫苗一直注射给婴儿，他们是该疾病的高危人群，而针对其他菌株的不同疫苗则注射给青少年。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"37684715aaf54a73b9fe52ee56a263cc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260320:nL4T408188:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE000M9KFDE8.USD","SG9999002224.SGD","IE00BLSP4452.SGD","LU0321505868.SGD","SG9999003800.SGD","SGXZ57979304.SGD","IE00B19Z3581.USD","BK4007","LU1983299246.USD","IE00B3T34201.USD","LU0321505439.SGD","LU0122379950.USD","LU1035777561.USD","LU1066053197.SGD","LU0306806265.USD","LU1046248800.SGD","LU1023059063.AUD","IE00B19Z3B42.SGD","LU0234572021.USD","LU0203347892.USD","IE00BBT3K403.USD","LU0971552673.USD","LU0058720904.USD","LU1670756490.USD","LU1202635105.USD","IE00BLSP4239.USD","BK5011","GSK","LU0161305163.EUR","LU0306807586.USD","LU0203345920.USD","LU0575583348.USD","LU0211331839.USD","IE00BQJZX424.USD","IE0034235071.USD","LU0545562505.USD","LU1400636491.USD","IE0002270589.USD","LU0985481810.HKD","LU1309081286.SGD","IE00BWDBJ516.SGD","BK4581","LU0289739699.SGD","LU1098665638.USD","LU1228905037.USD","LU1645745479.HKD","BK4568","LU1400636574.HKD","LU1481599808.USD","LU1400636657.SGD","SG9999002232.USD","BK4550","LU1057294990.SGD","SG9999001176.SGD","LU0868494617.USD","BK4534","BK4588","BK4592","LU1894683348.USD","LU1487256676.USD","BK4599","LU0225771236.USD","LU1228905540.USD","LU0109981661.USD","SG9999013999.USD","SG9999011175.SGD","LU0170899867.USD","LU1015430645.USD","LU1302929846.USD","BK4533","SG9999001176.USD","LU1066051498.USD","LU1481600234.SGD","LU0456855351.SGD","LU1894683264.USD","LU0971552830.HKD","LU0225284248.USD","BK4585","LU1064927863.SGD","LU1883839398.USD"],"gpt_icon":0},{"id":"1164912675","title":"Co-Diagnostics签署协议，大幅扩张南亚地区商业与分销版图","url":"https://stock-news.laohu8.com/highlight/detail?id=1164912675","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1164912675?lang=zh_cn&edition=fundamental","pubTime":"2026-03-20 20:00","pubTimestamp":1774008014,"startTime":"0","endTime":"0","summary":"Co-Diagnostics, Inc. (CODX) 已签署一项关键协议，旨在将其商业运营与产品分销网络广泛覆盖至南亚地区。此举标志着该公司在全球市场，尤其是在亚洲新兴经济体中的战略布局取得重大进展。通过本次合作，Co-Diagnostics有望显著提升其诊断产品在该区域的可及性与市场渗透率。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","CODX","BK4568"],"gpt_icon":0},{"id":"2620805757","title":"背景资料-过去几十年的大宗消费交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2620805757","media":"路透中文","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620805757?lang=zh_cn&edition=fundamental","pubTime":"2026-03-20 19:00","pubTimestamp":1774004432,"startTime":"0","endTime":"0","summary":"联合利华正在洽谈将其食品业务出售给规模较小的竞争对手麦考密克，这项潜在的交易将把这家英国公司的赫尔曼和康宝品牌与这家美国调味品制造商的乔鲁拉辣酱联合起来。2010 年 1 月 19 日 根据汤森路透的数据，卡夫食品公司以约 196 亿美元的价格收购了 英国糖果制造商吉百利，从而成为全球最大的糖果制造商，这也是有史以来欧洲最大的食品饮料交易。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"37684715aaf54a73b9fe52ee56a263cc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260320:nL4T4080U8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1989763427.SGD","LU0971552673.USD","LU0997586606.USD","SG9999013999.USD","LU0889565080.SGD","LU1244550221.USD","LU0731783394.SGD","LU2463526074.USD","IE00BLSP4239.USD","SG9999001440.SGD","LU0251131958.USD","LU0690374961.EUR","LU2242646821.SGD","LU1046421449.USD","IE00BVYPNW00.USD","LU0170899867.USD","LU1814569148.SGD","LU1244550494.USD","LU1699723380.USD","LU0553294199.USD","LU0128525929.USD","LU1023061713.HKD","LU0648001328.SGD","LU1201861249.SGD","LU0997587240.USD","LU0345770308.USD","LU0011850046.USD","LU1670756490.USD","LU2404859667.USD","LU1023061473.USD","BK4504","LU0985489474.SGD","LU1400636657.SGD","LU0171281750.USD","LU0345777659.USD","LU0312595415.SGD","LU2491050154.USD","SG9999002224.SGD","LU1481600234.SGD","03165","LU1489326972.SGD","LU0738911758.USD","BK4566","IE00BYV24P56.USD","SGXZ57979304.SGD","LU0048573561.USD","LU0320765489.SGD","LU1571399168.USD","GB00B4QBRK32.GBP","LU0310800965.SGD","LU0289739699.SGD","BK4599","IE00BVYPNV92.GBP","LU0130102774.USD","LU0964806797.USD","LU0980610538.SGD","LU1599440770.SGD","LU1046248800.SGD","LU1929549753.HKD","LU1863844749.USD","LU1280957306.USD","LU2404859741.USD","LU0215105999.USD","LU0058720904.USD","IE00BJTD4V19.USD","LU0708994859.HKD","LU2089284900.SGD","LU0345777147.USD","LU0772969993.USD","LU0321505439.SGD","LU0545039389.USD","LU0690374615.EUR","LU1003077747.HKD","LU1400636574.HKD","BK4585","BK4567","LU2491050071.SGD","LU1509826696.USD","LU0310800379.SGD","IE00BDGV0183.EUR","LU0640476718.USD","LU0575583348.USD","LU0302445910.USD","LU0208291251.USD","LU0889566641.SGD","LU0949170772.SGD","LU1150488135.SGD","LU1023059063.AUD","LU0792757196.USD","LU1078025761.USD","LU0072461881.USD","BK4533","BK4558","LU0048578792.EUR","LU0661504455.SGD","LU1015430645.USD","LU1244550577.SGD","LU2242652126.USD","LU1066053197.SGD","LU1400636491.USD","BK4113","LU0237698245.USD","BK4177","IE00B3PB1722.GBP","LU0211331839.USD","LU0868494617.USD","LU1051770623.HKD","SG9999003800.SGD","BK4588","IE00BVYPNT70.USD","LU0550127509.SGD","LU0130517989.USD","BK4183","BK4535","GB00B4LPDJ14.GBP","LU1267930573.SGD","SG9999001176.SGD","LU0006061336.USD","BK4568","LU0234572021.USD","LU0070302665.USD","LU2089283258.USD","LU2211817866.USD","IE0034235071.USD","LU1162221912.USD","IE00BN8TJ469.HKD","LU1267930227.SGD","LU0251142724.SGD","LU2271345857.HKD","LU1894683264.USD","BK4505","LU0506197887.SGD","LU2114397693.USD","IE00B42XCP33.USD","LU1894683348.USD","LU1267930813.SGD","LU1481011671.HKD","LU0320765646.SGD","IE0002270589.USD","BK4597","LU0122379950.USD","LU0477156953.USD","LU1487256676.USD","LU0985320562.USD","BK4212","IE000M9KFDE8.USD","LU0731783048.USD","LU0068578508.USD","LU0052756011.USD","LU0128525689.USD","LU1645745479.HKD","LU0997586432.USD","LU2111349929.HKD","LU3187612489.SGD","LU0225284248.USD","UL","LU0098860793.USD","BK5127","BK4018","BK4550","LU2091194634.USD","LU0742534661.SGD","SG9999002232.USD","SG9999001176.USD","LU0158827948.USD","IE00BGHQF631.EUR","IE00BVYPNS63.GBP","LU1066051498.USD","LU1302929846.USD","LU1057294990.SGD","LU1920062954.HKD","BK4559","LU1019632923.USD","LU1585245621.USD","LU2491049909.HKD","IE00B3T34201.USD","BK4581","LU2108987350.USD","BK4532","LU0971552830.HKD","LU0557290698.USD","LU1153584641.USD","LU1430594728.SGD","IE00BJTD4N35.SGD","LU0225771236.USD","IE00B19Z3B42.SGD","IE00BLSP4452.SGD","LU0306807586.USD","IE00BMCWC346.EUR","LU0345770993.USD","LU1863844665.USD","LU1883839398.USD","LU1119994140.HKD","BK4592","LU0878866978.SGD","LU0456855351.SGD","IE00BGHQDW50.EUR","LU1019634622.SGD","SG9999011175.SGD","LU2242646235.USD","LU0029864427.USD","LU2028103732.USD","IE00BFXG1179.USD","LU0158827781.USD","BK4007","LU0985481810.HKD","IE00BBT3K403.USD","LU1150488218.USD","LU0742537680.HKD","LU1481011911.USD","LU2023251221.USD","LU1989763690.USD","LU1920063259.USD","LU0162691827.USD","LU1481599808.USD","MKC","LU1003076772.USD","LU0321505868.SGD","LU2275660780.HKD","LU1202635105.USD","LU2401740654.USD","LU0433182093.SGD","LU0127657111.USD","LU0306806265.USD","BK4534","IE00B19Z3581.USD"],"gpt_icon":0},{"id":"2620639226","title":"外资再加码！医药巨头阿斯利康核药生产供应基地落子黄埔","url":"https://stock-news.laohu8.com/highlight/detail?id=2620639226","media":"21世纪经济报道","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620639226?lang=zh_cn&edition=fundamental","pubTime":"2026-03-19 21:36","pubTimestamp":1773927412,"startTime":"0","endTime":"0","summary":"3月19日，阿斯利康与广州经济技术开发区管理委员会正式签署战略合作框架协议，宣布将在广州开发区、黄埔区建设放射性偶联药物（RDC）生产供应基地。这是阿斯利康今年1月宣布系列投资中的重要一环，标志着这家全球生物医药巨头在核药这一前沿赛道完成战略布局的关键落子。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202603193677730187.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603193677730187.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1574","BK4568","159938","09939","IE00B3T34201.USD","LU2417539215.USD","LU2462157665.USD","BK4007","BK1515","LU0320765992.SGD","LU2456880835.USD","LU0889565916.HKD","BK4585","BK4588","LU1829250122.USD","LU2236285917.USD","LU0289739699.SGD","LU0109394709.USD","LU0058720904.USD","AZN","BK1161"],"gpt_icon":0},{"id":"2620225813","title":"吉利德科学(GILD.US)CD19/CD20 CAR-T细胞疗法启动III期临床","url":"https://stock-news.laohu8.com/highlight/detail?id=2620225813","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620225813?lang=zh_cn&edition=fundamental","pubTime":"2026-03-19 21:12","pubTimestamp":1773925932,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，3月18日，美国临床试验收录网站显示，吉利德科学旗下公司Kite Pharma启动了KITE-753的首个III期临床试验。KITE-753是一款靶向CD19和CD20的双顺反子自体CAR-T细胞疗法。研究的主要终点是第6个月实现完全缓解的患者比例和36个月内的无事件生存期。结果显示，剂量3队列，在14例未接受过CAR-T细胞疗法治疗的患者中，11例实现CR，CR率为79%;总人群，在20例未接受过CAR-T细胞疗法治疗的患者中，14例实现CR，CR率为70%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1416170.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2089984988.USD","LU1571399168.USD","LU1674673691.USD","GILD","LU1037948897.HKD","SG9999015986.USD","LU0965508806.USD","LU0965509010.AUD","SG9999015978.USD","LU0823416689.USD","LU0965509101.SGD","LU1061106388.HKD","LU0889565916.HKD","BK4568","LU1066051498.USD","LU0289739699.SGD","BK4139","LU1585245621.USD","IE00B3T34201.USD","LU0109394709.USD","LU1839511570.USD","IE00B19Z3B42.SGD","SG9999015945.SGD","LU0122379950.USD","IE00BZ1G4Q59.USD","LU2087621335.USD","SG9999015952.SGD","BK4588","LU0114720955.EUR","III","LU0058720904.USD","LU0234570918.USD","LU1066053197.SGD","IE0002270589.USD","LU1934455863.HKD","LU1037948541.HKD","IE00B19Z3581.USD","LU2112291526.USD","LU0882574055.USD","BK4583","LU1674673428.USD","LU0861579265.USD","LU0965509283.SGD","LU1430594728.SGD","IE00BKVL7J92.USD","CAR","BK4134","LU1023059063.AUD","BK4022","BK4532"],"gpt_icon":0},{"id":"2620003241","title":"阿斯利康将于广州建设放射性偶联药物生产供应基地","url":"https://stock-news.laohu8.com/highlight/detail?id=2620003241","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620003241?lang=zh_cn&edition=fundamental","pubTime":"2026-03-19 19:01","pubTimestamp":1773918091,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["AZN","LU0058720904.USD","LU1829250122.USD","LU2462157665.USD","LU0289739699.SGD","LU2236285917.USD","IE00B3T34201.USD","LU2417539215.USD","LU0889565916.HKD","BK4568","LU0320765992.SGD","BK4007","LU2456880835.USD","BK4585","LU0109394709.USD","BK4588"],"gpt_icon":0},{"id":"1115629984","title":"辉瑞：Talzenna联合Xtandi安全性符合各自已知安全特征，未发现新安全信号","url":"https://stock-news.laohu8.com/highlight/detail?id=1115629984","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115629984?lang=zh_cn&edition=fundamental","pubTime":"2026-03-19 18:48","pubTimestamp":1773917316,"startTime":"0","endTime":"0","summary":"辉瑞公司公布的数据显示，Talzenna与Xtandi联合用药的安全性特征与两种药物各自已知的安全性数据保持一致，研究期间未出现新的安全性信号。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BLSP4452.SGD","BK4550","LU1066053197.SGD","SG9999003800.SGD","LU1066051498.USD","BK4585","SG9999011175.SGD","LU0985481810.HKD","LU1023059063.AUD","IE00B19Z3581.USD","LU0456855351.SGD","LU0868494617.USD","BK4007","LU1894683348.USD","LU1894683264.USD","IE000M9KFDE8.USD","PFE","IE0002270589.USD","LU0306807586.USD","LU0170899867.USD","SG9999002232.USD","BK4581","LU0289739699.SGD","SG9999002224.SGD","LU0225284248.USD","SG9999001176.SGD","IE00B19Z3B42.SGD","BK4588","LU1057294990.SGD","LU0122379950.USD","SGXZ57979304.SGD","BK4592","BK4599","BK4568","LU0225771236.USD","LU0234572021.USD","LU1883839398.USD","LU0321505868.SGD","IE00BBT3K403.USD","LU0321505439.SGD","SG9999001176.USD","LU0306806265.USD","BK4534","IE00BLSP4239.USD","SG9999013999.USD","LU0058720904.USD","BK4533"],"gpt_icon":0},{"id":"1111610205","title":"Talzenna联合Xtandi显著改善转移性前列腺癌患者的影像学无进展生存期","url":"https://stock-news.laohu8.com/highlight/detail?id=1111610205","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1111610205?lang=zh_cn&edition=fundamental","pubTime":"2026-03-19 18:46","pubTimestamp":1773917215,"startTime":"0","endTime":"0","summary":"一项最新研究显示，将Talzenna与Xtandi联合使用，可显著提升转移性前列腺癌患者的影像学无进展生存期。这一积极结果有望为晚期前列腺癌的治疗提供新的有效方案。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0321505868.SGD","LU0306807586.USD","LU1023059063.AUD","SG9999003800.SGD","LU0234572021.USD","LU0058720904.USD","SG9999002232.USD","SG9999002224.SGD","BK4007","IE00BBT3K403.USD","LU0225284248.USD","LU0985481810.HKD","LU0122379950.USD","LU1066051498.USD","LU1066053197.SGD","BK4534","IE00BLSP4452.SGD","BK4533","SG9999001176.USD","LU0306806265.USD","BK4581","LU0289739699.SGD","SG9999013999.USD","BK4550","LU0170899867.USD","LU0868494617.USD","AZN","BK4568","BK4585","LU0456855351.SGD","SG9999011175.SGD","BK4592","IE00B19Z3581.USD","IE0002270589.USD","LU0321505439.SGD","BK4599","LU1057294990.SGD","SG9999001176.SGD","BK4588","LU1894683264.USD","IE000M9KFDE8.USD","IE00B19Z3B42.SGD","LU0225771236.USD","SGXZ57979304.SGD","PFE","LU1883839398.USD","LU1894683348.USD","IE00BLSP4239.USD"],"gpt_icon":0},{"id":"2620021540","title":"落子上海细胞治疗全链条，阿斯利康“深耕中国”迈入新阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=2620021540","media":"21世纪经济报道","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620021540?lang=zh_cn&edition=fundamental","pubTime":"2026-03-19 12:52","pubTimestamp":1773895925,"startTime":"0","endTime":"0","summary":"21世纪经济报道记者季媛媛上海报道在英国首相斯塔默访华带来中英经贸暖风的两个月后，英国制药巨头阿斯利康用实际行动为这一轮双边合作添上了浓墨重彩的一笔。3月19日，阿斯利康正式宣布了一项具有里程碑意义的布局：计划在上海建立细胞疗法商业化生产供应基地与创新中心。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202603193677171431.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603193677171431.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4588","LU0109394709.USD","LU0320765992.SGD","LU0889565916.HKD","LU1829250122.USD","AZN","LU0289739699.SGD","LU2236285917.USD","LU2462157665.USD","BK4585","LU2456880835.USD","BK4007","LU0058720904.USD","IE00B3T34201.USD","BK4568","LU2417539215.USD"],"gpt_icon":0},{"id":"2620290003","title":"阿斯利康宣布在上海建立细胞疗法商业化生产供应基地与创新中心","url":"https://stock-news.laohu8.com/highlight/detail?id=2620290003","media":"南方财经网","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620290003?lang=zh_cn&edition=fundamental","pubTime":"2026-03-19 10:54","pubTimestamp":1773888854,"startTime":"0","endTime":"0","summary":"南方财经3月19日电，阿斯利康今日宣布，计划在上海建立细胞疗法商业化生产供应基地与创新中心，将成为首家在中国拥有端到端细胞治疗能力的全球领先生物制药企业。同日，公司与上海市科学技术委员会及英国领先科研与金融机构签署多方合作谅解备忘录。据悉，阿斯利康将在上海自贸区临港新片区建设专门的细胞疗法商业化生产供应基地，用于在中国及其他亚洲市场商业化生产及供应自体CAR-T细胞疗法。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603193677128937.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["IE00B3T34201.USD","LU0109394709.USD","LU2236285917.USD","BK4568","LU2462157665.USD","LU2417539215.USD","LU1829250122.USD","LU2456880835.USD","BK4585","BK4588","LU0058720904.USD","LU0320765992.SGD","AZN","LU0889565916.HKD","LU0289739699.SGD","BK4007"],"gpt_icon":0},{"id":"2620297573","title":"阿斯利康中国区副总裁黄彬突然离职","url":"https://stock-news.laohu8.com/highlight/detail?id=2620297573","media":"消费日报财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620297573?lang=zh_cn&edition=fundamental","pubTime":"2026-03-19 09:59","pubTimestamp":1773885577,"startTime":"0","endTime":"0","summary":"3月18日，阿斯利康中国方面向记者确认，公司资深高管、阿斯利康中国副总裁、市场准入部门负责人黄彬正式离任。该人士为阿斯利康任职超20年的元老级高管，主导中国市场准入核心业务。截至记者发稿，黄彬本人暂未对外披露后续职业安排。公开资料显示，黄彬，1967年生，中国国籍，无境外永久居留权。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603193677031788.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["IE00B3T34201.USD","LU0289739699.SGD","LU0320765992.SGD","LU2462157665.USD","BK4568","LU0058720904.USD","AZN","LU0889565916.HKD","BK4007","LU1829250122.USD","LU2456880835.USD","LU2236285917.USD","LU0109394709.USD","LU2417539215.USD","BK4588","BK4585"],"gpt_icon":0},{"id":"2620292921","title":"再迎阿斯利康重磅布局！浦东生物医药产业究竟有啥“磁场效应”？","url":"https://stock-news.laohu8.com/highlight/detail?id=2620292921","media":"上观新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620292921?lang=zh_cn&edition=fundamental","pubTime":"2026-03-19 09:34","pubTimestamp":1773884072,"startTime":"0","endTime":"0","summary":"3月19日，张江科学城再添全球生物医药产业重磅布局——阿斯利康正式宣布在此建设细胞疗法创新中心。这个覆盖早期研究、病毒载体开发、临床生产及注册支持的全链条创新平台，将成为阿斯利康全球细胞疗法版图的关键枢纽，标志着中国在全球下一代细胞治疗领域的创新地位再获提升。生物医药产业是上海三大先导产业之一，也是新一轮科技革命和竞争的焦点赛道。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://biz.eastmoney.com/a/202603193676916419.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4568","399441","LU1829250122.USD","LU2456880835.USD","XBI","LU0889565916.HKD","BK4581","BK4007","LU0289739699.SGD","LU0320765992.SGD","LU2462157665.USD","161726","BK4588","AZN","LU2417539215.USD","BK4585","LU2236285917.USD","IE00B3T34201.USD","LU0109394709.USD","LU0058720904.USD"],"gpt_icon":0},{"id":"2620266216","title":"分析-TrumpRx 列出的许多药品价格高于在英国支付的价格","url":"https://stock-news.laohu8.com/highlight/detail?id=2620266216","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620266216?lang=zh_cn&edition=fundamental","pubTime":"2026-03-19 02:18","pubTimestamp":1773857895,"startTime":"0","endTime":"0","summary":"分析-TrumpRx 列出的许多药品价格高于在英国支付的价格TrumpRx 上约三分之一药品的英国价格**较低**TrumpRx 大幅降低肥胖症和生育药物的价格白宫达成协议后，制药商看到了对销售和利润的**喜忧参半的**影响 Bhanvi Satija/Michael Erman. 减肥药价格大幅下降路透评估了英国政府为每种处方药支付给药店的费用，以及目前参与的八家公司在 TrumpRx 上列出的价格。该公司称，TrumpRx提供了三种美国生育药物上市价格的84%折扣，这些药物通常在体外受精方案中一起使用。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"37684715aaf54a73b9fe52ee56a263cc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nL4T4061O6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SGXZ31699556.SGD","LU0942090050.USD","LU0971552673.USD","SG9999013999.USD","LU0310799852.SGD","LU0827474353.SGD","LU1098665638.USD","LU2896262040.SGD","LU1084165304.USD","LU0069063385.USD","IE00BVYPNW00.USD","LU0170899867.USD","LU0553294199.USD","LU0648001328.SGD","LU0784385170.HKD","LLII","LU0823416689.USD","LU1291159041.SGD","IE00B19Z9P08.USD","LU1868836757.USD","IE0001KFT4U8.USD","LU1127390331.HKD","LU0011850046.USD","LU1309081286.SGD","LU1046234339.USD","LU0757432116.USD","SG9999002224.SGD","LU2106854487.HKD","LU0234570918.USD","LU0969580561.USD","LU1571399168.USD","LU0353189680.USD","LU1934455277.USD","IE00BVYPNV92.GBP","LU0058720904.USD","LU0203202063.USD","LU0345777147.USD","BK4585","LU1093756325.SGD","LU0266013472.USD","LU0310800379.SGD","IE00BDGV0183.EUR","IE0005OL40V9.USD","LU2129689605.HKD","LU1078025761.USD","LU0661504455.SGD","LU1196500208.SGD","LU1066053197.SGD","IE00BJLML261.HKD","SG9999003800.SGD","IE00BKPKM643.USD","BK4578","LU2361044865.SGD","LU0130517989.USD","SG9999001176.SGD","IE00BJJMRZ35.SGD","BK4568","LU1228905037.USD","LU2087621335.USD","LU2746668974.SGD","SG9999018857.SGD","LU1035773651.USD","LU1934455863.HKD","IE0034235071.USD","LU2237443549.SGD","LU1267930227.SGD","IE00BZ1G4Q59.USD","LU1170363599.USD","LU2271345857.HKD","LU1917777945.USD","LU0511384066.AUD","LU1066051811.HKD","LU0203345920.USD","LU0114720955.EUR","LU2552382058.USD","LU0920840948.USD","IE00BFSS7M15.SGD","LU0820561909.HKD","LU1267930813.SGD","LU0320765646.SGD","LU2168563687.JPY","LU1487256676.USD","IE00BK4W5M84.HKD","LU1941712264.USD","LU0795875086.SGD","BK5011","LU0128525689.USD","LU2111349929.HKD","LU0109391861.USD","LU0225284248.USD","IE00BFSS8Q28.SGD","LU1116320737.USD","LU2091194634.USD","SG9999001176.USD","LU2023250843.SGD","LU2023250504.SGD","LU0211326839.USD","LU0957799991.USD","LU1057294990.SGD","LU2746668461.USD","IE0004445015.USD","LU1153584641.USD","BK4532","LU0557290698.USD","LU1064131342.USD","LU1064927863.SGD","LU0306807586.USD","LU2462157665.USD","LU0861579265.USD","LU0171293334.USD","LU0265550946.USD","LU2750360641.GBP","IE00BFXG1179.USD","LU1720051108.HKD","BK4007","LU0960981461.USD","LU1974910355.USD","LU1104425308.USD","LU1732799900.SGD","LU2125909247.SGD","LU1003076772.USD","LU1551013425.SGD","LU0526926950.USD","IE00BFTCPJ56.SGD","LU1032955483.USD","LU0882574055.USD","LU0640478417.SGD","LU0820561818.USD","LU0306806265.USD","LU2023250330.USD","LU0070217475.USD","LU0784384876.USD","IE00B19Z3581.USD","LU2505996681.GBP","LU0889565080.SGD","LU1244550221.USD","LU0683600562.USD","PFE","SG9999014898.SGD","IE00BLSP4239.USD","LU2237443978.SGD","SG9999001440.SGD","LU1868836914.USD","LU1880407132.USD","LU1941712348.USD","LU0047473722.SGD","LU1699723380.USD","LU0128525929.USD","LU1201861249.SGD","BK4516","LU0109981661.USD","SG9999015945.SGD","LU0965508806.USD","LU0787776722.HKD","LU1037948541.HKD","LU0345777659.USD","SGXZ51526630.SGD","BK4566","LU0390134368.USD","LU0289739699.SGD","LU2264538146.SGD","LU0964806797.USD","LU1280957306.USD","SG9999015358.SGD","IE0034235303.USD","LU0545039389.USD","LU2089984988.USD","GB00BDT5M118.USD","SG9999014880.SGD","LU1323610961.USD","LU0208291251.USD","LU0889566641.SGD","LU0949170772.SGD","LU0792757196.USD","LU1015430645.USD","LU1674673691.USD","LU1051770623.HKD","LU2237438978.USD","LU1496350171.SGD","LU1988902786.USD","LU2125154935.USD","LU1228905540.USD","LU1232071149.USD","LU0784383803.USD","LU0096364046.USD","LU0234572021.USD","IE00B4R5TH58.HKD","LU2089283258.USD","IE00BN8TJ469.HKD","LU1035777561.USD","LU2168564149.EUR","LU1868837136.USD","SG9999014542.SGD","LU2417539215.USD","LU1301847155.USD","LU2114397693.USD","IE00B42XCP33.USD","LU0265550359.USD","LU0345769631.USD","LU0985320562.USD","LU0211328371.USD","LU1839511570.USD","LU0052756011.USD","LU0106261372.USD","LU0098860793.USD","LU1623119135.USD","BK4550","IE00BGHQF631.EUR","LU1302929846.USD","LU1880407215.USD","LU2430703251.USD","LU1585245621.USD","LU2756315318.SGD","GSK","BK4581","LU0971552830.HKD","LU0472753341.HKD","BK4139","IE00B19Z3B42.SGD","IE00BKDWB100.SGD","IE00BLSP4452.SGD","LU1732800096.USD","IE00B775H168.HKD","LU2028103732.USD","LU0158827781.USD","LU0985481810.HKD","IE00BBT3K403.USD","SG9999018865.SGD","LU0323591593.USD","LU0965509283.SGD","LU1629891620.HKD","LU1914381329.SGD","LU0079474960.USD","LU2063271972.USD","BK4534","LU2471134879.HKD","IE00BKPKM429.USD","LU2360106947.USD","LU0965509101.SGD","LU0949170426.SGD","LU1496350502.SGD","LU1989772840.SGD","IE00BQJZX424.USD","LU0354030511.USD","LU2168564495.EUR","LU0417517546.SGD","LU2471134952.CNY","IE00BWXC8680.SGD","LU1037948897.HKD","LU0496365809.HKD","LU0345770308.USD","LU2552382132.HKD","LU2552382215.SGD","LU1670756490.USD","LU1506573853.SGD","IE00B7KXQ091.USD","LU1548497426.USD","BK4504","LU2087625088.SGD","IE00B1BXHZ80.USD","LU2279689827.SGD","LU2491050154.USD","LU0920783379.SGD","LU1481600234.SGD","LU2211815571.USD","LU2213496289.HKD","03165","LU1069347547.HKD","SG9999014906.USD","LU0320765489.SGD","LU1989771016.USD","IE00BJJMRY28.SGD","LU0310800965.SGD","LU0471298694.HKD","BK4599","ELIS","LU0130102774.USD","SG9999015952.SGD","LU0354030438.USD","LU1046248800.SGD","LU0432979614.USD","LU1929549753.HKD","LU2471134796.USD","LU1153585028.USD","LU2089284900.SGD","LU0784385840.USD","IE00BSNM7G36.USD","LU2125154778.USD","LU1003077747.HKD","LU1267930730.SGD","LU0823399737.USD","LU2505996509.AUD","LU0320765059.SGD","LU2433249047.HKD","LU0965509010.AUD","LU1023059063.AUD","BK4533","LU0256863811.USD","LU1923622614.USD","LU1244550577.SGD","LU0882574139.USD","LU1061106388.HKD","LU0689626769.HKD","IE00B3PB1722.GBP","LU0211331839.USD","LU0868494617.USD","LU2360032135.SGD","LU2237443382.USD","LU0868494708.USD","LU1718418525.SGD","AZN","LU1267930573.SGD","LU1267930490.SGD","LU1366192091.USD","LU0070302665.USD","LU0353189763.USD","LU1145028129.USD","LU0097036916.USD","LU2125909593.SGD","LU0061475181.USD","LU1894683264.USD","LU0203347892.USD","LU1035775433.USD","LU0256863902.USD","NVO","LU1674673428.USD","ELIL","LU1032466523.USD","LU1894683348.USD","IE0002270589.USD","LU0122379950.USD","LU0477156953.USD","LU1868836591.USD","LU2468319806.SGD","LU1069344957.HKD","LU2592432038.USD","IE000M9KFDE8.USD","LU1935042991.SGD","LU0997586432.USD","SG9999015341.SGD","LU2347655156.SGD","LU0857590862.USD","LU0320765992.SGD","LU1221951046.USD","LU0203201768.USD","LU0689472784.USD","IE0004445239.USD","LU2491049909.HKD","LU1019632923.USD","LU0077335932.USD","IE00B3T34201.USD","LU2108987350.USD","LU0109394709.USD","IE0002141913.USD","LLY","SG9999014559.SGD","LU0963555726.SGD","LU0211327993.USD","LU1019634622.SGD","LU2361044949.HKD","LU1261432733.SGD","LU0029864427.USD","LU1712237335.SGD","LU0823434583.USD","IE00B7SZLL34.SGD","LU2023251221.USD","LU1481599808.USD","LU1059921491.USD","LU2430703178.SGD","LU0912757837.SGD","SG9999015978.USD","LU1202635105.USD","LU2750360997.AUD","LU0006306889.USD","LU0466842654.USD","LU1074936037.SGD","LU0887340254.USD","IE00B4JS1V06.HKD","LU2756315664.SGD","LU0672654240.SGD","LU1093756168.USD","LU0047473722.EUR","LU1551013342.USD","LU2129689514.USD","LU2168564222.USD","LLYX","SG9999014575.USD","IE0009355771.USD","LU2602419157.SGD","LU1814569148.SGD","LU1244550494.USD","IE00B1XK9C88.USD","SG9999014567.USD","LU0708995401.HKD","LU1934455194.USD","BK4583","LU0499090636.EUR","LU2539964713.USD","LU0471298777.SGD","LU2456880835.USD","LU1400636657.SGD","IE0034235188.USD","LU0345769128.USD","LU0738911758.USD","LU0238689110.USD","IE00B2B36J28.USD","SGXZ57979304.SGD","LU0786609619.USD","LU0976567544.SGD","LU2357305700.SGD","LU0980610538.SGD","LU0211326755.USD","LU0708994859.HKD","LU1400636574.HKD","LU0321505439.SGD","LU0289961442.SGD","LU2491050071.SGD","LU2430703095.HKD","LU0289739343.SGD","LU0640476718.USD","LU0575583348.USD","IE00BJT1NW94.SGD","LU0545562505.USD","LU1778281490.HKD","LU1116320901.HKD","LU0385154629.USD","LU1400636491.USD","IE00B19Z9Z06.USD","IE00BWDBJ516.SGD","SG9999015986.USD","LU1804176565.USD","LU0225283273.USD","BK4588","LU0964807845.USD","LU0972486137.USD","LU2471134523.USD","LU2168564065.EUR","LU0889565916.HKD","LU0057025933.USD","LU0795875169.SGD","LLYZ","LU1162221912.USD","SGXZ99366536.SGD","IE00BK4W5L77.USD","LU0161305163.EUR","LU2324357040.USD","LU1119994496.HKD","LU2461242641.AUD","LU1645745479.HKD","LU2293690249.USD","IE00BKVL7J92.USD","LU1989772923.USD","SG9999002232.USD","LU2265009873.SGD","LU0158827948.USD","LU1066051498.USD","BK4559","LU0210536198.USD","SG9999014914.USD","LU2237443895.HKD","LU2237443465.HKD","LU1221951129.SGD","LU1430594728.SGD","LU1868837300.USD","LU0225771236.USD","LU1066051225.USD","LU1983299246.USD","LU0124676726.USD","LU1883839398.USD","IE00B894F039.SGD","BK4592","SG9999017495.SGD","LU0456855351.SGD","LU2129689431.USD","LU2236285917.USD","LU1720051017.SGD","SG9999011175.SGD","LU0820562030.AUD","LU0316494557.USD","LU2361045086.USD","LU0321505868.SGD","IE00BJJMRX11.SGD","LU0823434740.USD","LU0094547139.USD","LU0943347566.SGD","LU2133065610.SGD","SGXZ81514606.USD","LU0198837287.USD","LU2293690082.USD","LU0345770993.USD","IE00BN29S564.USD","LU2237443622.USD","LU2112291526.USD"],"gpt_icon":0},{"id":"2620656257","title":"BUZZ-艾伯维下跌，因强生银屑病药物增加竞争风险","url":"https://stock-news.laohu8.com/highlight/detail?id=2620656257","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620656257?lang=zh_cn&edition=fundamental","pubTime":"2026-03-18 22:55","pubTimestamp":1773845721,"startTime":"0","endTime":"0","summary":"BUZZ-艾伯维下跌，因强生银屑病药物增加竞争风险3月18日 - ** 制药商艾伯维ABBV.N股价早盘下跌3.3%至212.67美元 ** 法国巴黎银行维持艾伯维 \"中性 \"评级，目标价为213美元** 券商称，J&J获得FDA批准的每日一次口服银屑病药物Icotyde可能与艾伯维的Skyrizi形成竞争，而Skyrizi是艾伯维增长的主要动力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"37684715aaf54a73b9fe52ee56a263cc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nL4S4061EI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2133065610.SGD","LU0553294199.USD","LU1037948897.HKD","LU0069063385.USD","BK4534","BK4568","LU1074936037.SGD","SG9999015978.USD","LU0345770308.USD","IE00BVYPNV92.GBP","JNJ","LU0787776722.HKD","LU1430594728.SGD","LU1934455194.USD","LU1934455863.HKD","LU0345769631.USD","LU1059921491.USD","LU0289739343.SGD","LU0256863811.USD","IE000M9KFDE8.USD","ABBV","IE00B3PB1722.GBP","LU2468319806.SGD","IE00BFXG1179.USD","SG9999015945.SGD","LU1894683264.USD","LU0234570918.USD","LU1914381329.SGD","LU1732800096.USD","BK4533","LU0158827948.USD","LU2430703251.USD","LU2471134952.CNY","LU0170899867.USD","LU0640476718.USD","LU0912757837.SGD","LU2237443382.USD","BK4532","LU0738911758.USD","LU0965509283.SGD","BK4581","LU1551013425.SGD","LU1057294990.SGD","LU1989772840.SGD","LU1221951046.USD","LU0124676726.USD","LU1244550221.USD","LU0882574055.USD","LU1894683348.USD","BK4504"],"gpt_icon":0},{"id":"2620259472","title":"强生治疗银屑病的口服药物获美国FDA批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2620259472","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620259472?lang=zh_cn&edition=fundamental","pubTime":"2026-03-18 21:22","pubTimestamp":1773840123,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["IE00B3PB1722.GBP","LU0234572021.USD","LU0122379950.USD","LU2129689605.HKD","LU0098860793.USD","IE00B2B36J28.USD","LU0792757196.USD","BK4581","LU1032955483.USD","LU2750360641.GBP","LU0912757837.SGD","LU2129689514.USD","LU2468319806.SGD","JNJ","IE00BVYPNV92.GBP","LU0114720955.EUR","BK4007","IE00B3T34201.USD","LABU","IE00B42XCP33.USD","LU0203347892.USD","IE00B1BXHZ80.USD","IE00BLSP4239.USD","IE00BSNM7G36.USD","LU1496350502.SGD","IE000M9KFDE8.USD","LU1066051811.HKD","LU2430703095.HKD","LU2112291526.USD","IE00BGHQF631.EUR","LU2133065610.SGD","LU0203345920.USD","LU0689626769.HKD","LU1267930813.SGD","LU2592432038.USD","LU1894683348.USD","LU2347655156.SGD","BK4592","LU1244550494.USD","BK4568","IE0002270589.USD","LU1221951129.SGD","LU2471134523.USD","LU0795875169.SGD","LU1074936037.SGD","LU1066051498.USD","BK4533","LU1023059063.AUD","IE00B4R5TH58.HKD","BK4559"],"gpt_icon":0},{"id":"2620241259","title":"辉瑞(PFE.US)潜在“first-in-class”小分子组合疗法达主要终点","url":"https://stock-news.laohu8.com/highlight/detail?id=2620241259","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620241259?lang=zh_cn&edition=fundamental","pubTime":"2026-03-18 21:21","pubTimestamp":1773840109,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，辉瑞3月18日宣布，其2期FOURLIGHT-1研究达到主要终点。该积极结果支持辉瑞推进atirmociclib在一线治疗及早期疾病中的开发策略，在这些人群中，实现更持久的内分泌治疗疾病控制，有望带来更大的临床获益。Atirmociclib是一种在研、潜在“first-in-class”的口服CDK4抑制剂。该药物由辉瑞发现，目前正用于开发治疗HR阳性、HER2阴性乳腺癌。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1415608.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"辉瑞(PFE.US)潜在“first-in-class”小分子组合疗法达主要终点","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1066053197.SGD","LU1023059063.AUD","LU0058720904.USD","IE000M9KFDE8.USD","LU0306806265.USD","BK4599","BK4550","SG9999011175.SGD","LU1894683348.USD","SGXZ57979304.SGD","PFE","IE0002270589.USD","LU1894683264.USD","BK4581","IE00BLSP4452.SGD","LU0321505868.SGD","BK4592","BK4007","LU0225771236.USD","SG9999013999.USD","SG9999002224.SGD","SG9999002232.USD","LU1057294990.SGD","SG9999003800.SGD","BK4534","LU0456855351.SGD","LU0306807586.USD","SG9999001176.USD","LU0289739699.SGD","IE00B19Z3581.USD","LU1066051498.USD","BK4568","LU0122379950.USD","LU0985481810.HKD","LU0234572021.USD","LU0170899867.USD","LU0868494617.USD","BK4533","IE00BBT3K403.USD","IE00B19Z3B42.SGD","SG9999001176.SGD","IE00BLSP4239.USD","LU1883839398.USD","BK4585","LU0321505439.SGD","LU0225284248.USD","BK4588"],"gpt_icon":1}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":67,"code":"91000000","status":"200"}]}}